Page last updated: 2024-10-22

rtki cpd and Innate Inflammatory Response

rtki cpd has been researched along with Innate Inflammatory Response in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Acute lung injury was efficiently treated by inhibiting the cascade of inflammation, and reducing the inflammatory response in the lung."5.62Design, synthesis and structure-activity relationship studies of 4-indole-2-arylaminopyrimidine derivatives as anti-inflammatory agents for acute lung injury. ( Chen, T; Wei, Y; Zhang, X; Zhao, H; Zhu, G, 2021)
"Acute lung injury was efficiently treated by inhibiting the cascade of inflammation, and reducing the inflammatory response in the lung."1.62Design, synthesis and structure-activity relationship studies of 4-indole-2-arylaminopyrimidine derivatives as anti-inflammatory agents for acute lung injury. ( Chen, T; Wei, Y; Zhang, X; Zhao, H; Zhu, G, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, T1
Wei, Y1
Zhu, G1
Zhao, H1
Zhang, X1

Other Studies

1 other study available for rtki cpd and Innate Inflammatory Response

ArticleYear
Design, synthesis and structure-activity relationship studies of 4-indole-2-arylaminopyrimidine derivatives as anti-inflammatory agents for acute lung injury.
    European journal of medicinal chemistry, 2021, Dec-05, Volume: 225

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cytokines; Dose-Resp

2021